You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AKT signaling

Showing 1 - 25 of 1,498
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

Recruiting
  • Esophagus Adenocarcinoma
  • +2 more
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Signaling Pathways Targeting Colorectal Cancer in Egypt

Completed
  • Colorectal Cancer
  • Markers in tissue samples: (TIGAR , TRIM59, P53, AKT, GSH)
  • Assiut, Egypt
    Assiut University- faculty of medicine -Medical biochemistry dep
May 7, 2020

Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

Not yet recruiting
  • Esophageal Adenocarcinoma
  • +2 more
  • Palo Alto, California
  • +5 more
Jan 12, 2023

High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

Not yet recruiting
  • High-Risk Prostate Cancer
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Jan 17, 2023

Klotho _ LRP-6 _ Gastric Adenocarcinoma

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Prognostic study
  • (no location specified)
Jan 29, 2023

Bile Acids in Acute Insulin Resistance

Recruiting
  • PI3K Gene Mutation
  • +4 more
  • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022

Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

Not yet recruiting
  • PIK3CA-related Overgrowth Spectrum
  • +8 more
  • national registry
  • Paris, France
    Translational medicine and Targeted therapies unit, Hôpital Neck
Sep 28, 2022

Intensive Care Unit Acquired Weakness, Critical Illness Trial in Aarhus (KetoneAid KE4 Pro Monoester, Maltodextrin and fat-based

Not yet recruiting
  • Intensive Care Unit Acquired Weakness
  • Critical Illness
  • KetoneAid KE4 Pro Monoester
  • Maltodextrin and fat-based placebo
  • Aarhus, Denmark
    Aarhus University Hospital
Nov 2, 2022

Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Dapagliflozin 10mg
  • New Haven, Connecticut
    Yale Cancer Center Smilow Cancer Hospital
Aug 3, 2023

Burns Trial in Toronto (, propranolol)

Active, not recruiting
  • Burns
  • Toronto, Ontario, Canada
    Ross Tilley Burn Centre - Sunnybrook HSC
Mar 24, 2022

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Breast Tumors Trial in Zhengzhou (Pyrotinib Maleate, Dalpiciclib Isethionate Tablets, Inetetamab)

Recruiting
  • Breast Neoplasms
  • Pyrotinib Maleate
  • +3 more
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jun 1, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)

Active, not recruiting
  • Breast Cancer
  • +2 more
  • New York, New York
    Columbia University Medical Center - Herbert Irving Cancer Cente
Aug 16, 2022

Carcinoma Cervix,Stage III Trial in Mumbai (Nelfinavir, Cisplatin, Pelvic EBRT and Brachytherapy)

Recruiting
  • Carcinoma Cervix,Stage III
  • Mumbai, Maharashtra, India
    Tata Memorial Centre
Feb 18, 2022

Proteus Syndrome Trial run by the NHGRI (MK-7075 (miransertib))

Recruiting
  • Proteus Syndrome
  • MK-7075 (miransertib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 19, 2022

Hormonal Sensitivity in Noonan and LEOPARD Syndromes

Completed
  • Noonan Syndrome
  • LEOPARD Syndrome
    • Toulouse, France
      CIC de Toulouse- Unité pediatrique
    Aug 25, 2021

    Relapsed/Refractory Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Leukemia Trial in France

    Recruiting
    • Relapsed/Refractory Acute Lymphoblastic Leukemia
    • T-cell Acute Lymphoblastic Leukemia
      • Amiens, France
      • +30 more
      Apr 14, 2023

      Cholangiocarcinoma, Bile Duct Tumor, Biliary Tract Malignancy Trial run by the National Cancer Institute (NCI) (Tivozanib)

      Recruiting
      • Cholangiocarcinoma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 6, 2022

      miRNA as a Growth Plate Marker After GH

      Recruiting
      • MicroRNAs: D13.444.735.790.552.500
        • São Paulo, SP, Brazil
          Santa Casa SP School of Medical Sciences
        Jul 7, 2023

        Type2 Diabetes, Insulin Resistance Trial in Odense (Acute exercise)

        Completed
        • Type2 Diabetes
        • Insulin Resistance
        • High intensity interval training
        • Odense, Denmark
          Department of Endocrinology, Odense University Hospital
        Aug 31, 2022

        Prostate Cancer, Insulin Resistance, Diabetes, Type 2 Trial in Buffalo (Pioglitazone 30 mg, Placebo)

        Recruiting
        • Prostate Cancer
        • +3 more
        • Pioglitazone 30 mg
        • Placebo
        • Buffalo, New York
          Diabetes and Endocrinology Research Center of WNY
        Oct 26, 2022

        Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Bortezomib, Metformin Hydrochloride,

        Active, not recruiting
        • Recurrent Plasma Cell Myeloma
        • Refractory Plasma Cell Myeloma
        • Jacksonville, Florida
        • +1 more
        Jan 5, 2023

        Insulin Resistance, Hyperinsulinism, Immune System Trial in Nîmes (Blood test)

        Recruiting
        • Insulin Resistance
        • +2 more
        • Blood test
        • Nîmes, Gard, France
        • +1 more
        Sep 23, 2022

        HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma Trial in Houston (L-NMMA)

        Recruiting
        • HER2-negative Breast Cancer
        • +3 more
        • Houston, Texas
          Houston Methodist Neal Cancer Center
        Jan 12, 2023